Search results
Original Medicare vs. Medicare Advantage: Which Should You Trust Your Health To?
Investopedia· 4 days agoIf you already have Medicare Parts A and B (or soon will), you can choose to receive your Medicare...
Amazon Pharmacy expands to Medicare enrollees
The Hill via AOL· 6 days agoAmazon Pharmacy will expand its subscription service to enrollees of Medicare insurance plans, the company announced Tuesday. The expansion will be...
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
CNBC· 7 days agoAshkenazi, who will step in as the new CFO of Alphabet on July 31, has been key to managing the...
Amazon Widens RxPass Eligibility To Include Prime Members With Medicare
Investopedia via Yahoo Finance· 5 days agoAmazon said Tuesday it is expanding eligibility for its $5 monthly Pharmacy RxPass subscription to...
Opinion: Silent crisis in rural America is Medicare's diminishing value post Inflation Reduction Act
Tulsa World· 4 days agoFor decades, Medicare has served as a crucial pillar of health care for America's seniors,...
Health Care Week in Review: House and Senate Reintroduced MA Prior Authorization Bill, and House E&C...
JD Supra· 6 days agoBelow is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance;...
US Drug Negotiations Plan Shifts Focus for Rare Disease Programs
Bloomberg Law· 7 days agoThe rare disease community is pushing for changes in the Inflation Reduction Act’s drug price-setting scheme as it leads more drugmakers and investors to reconsider development ...
Subtle victory for Sanders in Novo spat
Politico· 5 days agoBI makes the blockbuster diabetes drug Jardiance, one of the 10 products subject to the first tranche...population received opioid use disorder drugs and 6.2 percent filled ...
Older Americans worry they can’t afford their own health care | CNN
CNN.com· 6 days agoTens of millions of seniors are similarly anxious about being able to afford health care because of...
Gateway - Quartz
Quartz· 6 days agoThe first biosimilar to enter the market is Amgen’s Amjevita, which was launched in the US on Jan. 31, 2023. The drug will be available in the US at two ...
